Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Thrombosis Events Tied To Gene Mutation In Stent Patients On Clopidogrel

This article was originally published in The Pink Sheet Daily

Executive Summary

Three independent research teams say they have document a strong link between a metabolizing gene and the prognosis for stented heart disease patients taking the standard anti-platelet medicine Plavix.

You may also be interested in...



Lilly, Daiichi Explore Pharmacogenomic Marker For Prasugrel

A May 4 Circulation article describing prasugrel's efficacy in patients who carry a genetic marker indicative of non-response to Plavix may be the opening volley in one of the first big marketing battles of the personalized medicine era

Lilly, Daiichi Explore Pharmacogenomic Marker For Prasugrel

A May 4 Circulation article describing prasugrel's efficacy in patients who carry a genetic marker indicative of non-response to Plavix may be the opening volley in one of the first big marketing battles of the personalized medicine era

Daiichi Sankyo, Lilly Explore Pharmacogenomic Marker For Prasugrel

A May 4 Circulation article describing prasugrel's efficacy in patients who carry a genetic marker indicative of non-response to Plavix may be the opening volley in one of the first big marketing battles of the personalized medicine era

Related Content

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS068453

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel